Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 31% ± 17% | |
| endothelial cell of vascular tree | 7 studies | 37% ± 16% | |
| vein endothelial cell | 4 studies | 30% ± 14% | |
| endothelial cell of lymphatic vessel | 3 studies | 36% ± 12% | |
| pancreatic A cell | 3 studies | 34% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreas | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 3403.13 | 328 / 328 | 93% | 16.88 | 165 / 178 |
| stomach | 95% | 1171.26 | 340 / 359 | 87% | 24.97 | 250 / 286 |
| lung | 79% | 815.53 | 458 / 578 | 66% | 8.48 | 758 / 1155 |
| intestine | 53% | 153.30 | 513 / 966 | 88% | 20.20 | 465 / 527 |
| thymus | 60% | 193.91 | 392 / 653 | 67% | 9.39 | 405 / 605 |
| bladder | 67% | 320.81 | 14 / 21 | 53% | 6.69 | 266 / 504 |
| esophagus | 46% | 193.98 | 662 / 1445 | 73% | 20.53 | 134 / 183 |
| uterus | 41% | 170.49 | 70 / 170 | 72% | 8.63 | 329 / 459 |
| breast | 67% | 1381.18 | 309 / 459 | 36% | 3.20 | 407 / 1118 |
| prostate | 50% | 145.90 | 123 / 245 | 51% | 3.63 | 258 / 502 |
| ovary | 17% | 49.13 | 30 / 180 | 73% | 12.57 | 315 / 430 |
| adipose | 88% | 1467.96 | 1057 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 15% | 48.89 | 38 / 258 | 64% | 19.49 | 148 / 230 |
| kidney | 48% | 161.34 | 43 / 89 | 27% | 1.70 | 245 / 901 |
| heart | 67% | 223.02 | 574 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 62% | 4.66 | 28 / 45 |
| skin | 51% | 222.46 | 931 / 1809 | 7% | 0.33 | 35 / 472 |
| blood vessel | 44% | 192.95 | 589 / 1335 | 0% | 0 | 0 / 0 |
| liver | 20% | 47.56 | 46 / 226 | 18% | 2.46 | 75 / 406 |
| brain | 22% | 47.03 | 578 / 2642 | 11% | 0.48 | 81 / 705 |
| muscle | 31% | 91.91 | 252 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.61 | 6 / 29 |
| spleen | 7% | 13.16 | 16 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 2% | 2.54 | 16 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030155 | Biological process | regulation of cell adhesion |
| GO_0002528 | Biological process | regulation of vascular permeability involved in acute inflammatory response |
| GO_0002675 | Biological process | positive regulation of acute inflammatory response |
| GO_0005634 | Cellular component | nucleus |
| Gene name | C2CD4B |
| Protein name | C2 calcium-dependent domain-containing protein 4B (Nuclear-localized factor 2) (Protein FAM148B) |
| Synonyms | FAM148B NLF2 |
| Description | FUNCTION: May be involved in inflammatory process. May regulate cell architecture and adhesion. . |
| Accessions | A6NLJ0 ENST00000380392.4 |